JP2017526738A5 - - Google Patents

Download PDF

Info

Publication number
JP2017526738A5
JP2017526738A5 JP2017527185A JP2017527185A JP2017526738A5 JP 2017526738 A5 JP2017526738 A5 JP 2017526738A5 JP 2017527185 A JP2017527185 A JP 2017527185A JP 2017527185 A JP2017527185 A JP 2017527185A JP 2017526738 A5 JP2017526738 A5 JP 2017526738A5
Authority
JP
Japan
Prior art keywords
composition
hydrophobic
hydrophilic
topical
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017527185A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017526738A (ja
JP6538166B2 (ja
Filing date
Publication date
Priority claimed from PCT/US2014/050345 external-priority patent/WO2015021382A2/en
Application filed filed Critical
Priority claimed from PCT/US2015/013043 external-priority patent/WO2016022170A1/en
Publication of JP2017526738A publication Critical patent/JP2017526738A/ja
Publication of JP2017526738A5 publication Critical patent/JP2017526738A5/ja
Application granted granted Critical
Publication of JP6538166B2 publication Critical patent/JP6538166B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017527185A 2013-08-08 2015-01-27 局所用組成物およびそれを使用する方法 Active JP6538166B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361863541P 2013-08-08 2013-08-08
US201361868139P 2013-08-21 2013-08-21
PCT/US2014/050345 WO2015021382A2 (en) 2013-08-08 2014-08-08 Topical compositions and methods of using the same
USPCT/US2014/050345 2014-08-08
PCT/US2015/013043 WO2016022170A1 (en) 2014-08-08 2015-01-27 Topical emulsions

Publications (3)

Publication Number Publication Date
JP2017526738A JP2017526738A (ja) 2017-09-14
JP2017526738A5 true JP2017526738A5 (https=) 2018-02-22
JP6538166B2 JP6538166B2 (ja) 2019-07-03

Family

ID=52462049

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2016533467A Active JP6513667B2 (ja) 2013-08-08 2014-08-08 局所用組成物およびそれを使用する方法
JP2017527185A Active JP6538166B2 (ja) 2013-08-08 2015-01-27 局所用組成物およびそれを使用する方法
JP2018247068A Pending JP2019077700A (ja) 2013-08-08 2018-12-28 局所用組成物およびそれを使用する方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2016533467A Active JP6513667B2 (ja) 2013-08-08 2014-08-08 局所用組成物およびそれを使用する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018247068A Pending JP2019077700A (ja) 2013-08-08 2018-12-28 局所用組成物およびそれを使用する方法

Country Status (10)

Country Link
US (3) US11813284B2 (https=)
EP (1) EP3030266B1 (https=)
JP (3) JP6513667B2 (https=)
KR (3) KR102321169B1 (https=)
CN (1) CN105979969B (https=)
AU (2) AU2014305778B2 (https=)
BR (2) BR112016002387B1 (https=)
CA (1) CA2920110C (https=)
ES (1) ES2836132T3 (https=)
WO (1) WO2015021382A2 (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1871433B1 (en) 2005-03-24 2009-04-22 NOLabs AB Cosmetic treatment with nitric oxide, device for performing said treatment and manufacturing method therefor
EP1888510A4 (en) 2005-05-27 2013-01-16 Univ North Carolina NITROGEN OXIDE-RELATED PARTICLES FOR NITROGEN OXIDE THERAPEUTICS AND BIOMEDICAL APPLICATIONS
JP5548121B2 (ja) 2007-05-14 2014-07-16 リサーチ ファウンデーション オブ ステイト ユニバーシティ オブ ニューヨーク バイオフィルム中の細菌細胞における生理学的分散応答の誘導
WO2013006613A1 (en) 2011-07-05 2013-01-10 Novan, Inc. Methods of manufacturing topical compositions and apparatus for same
ES2804263T3 (es) 2011-07-05 2021-02-05 Novan Inc Composiciones tópicas
ES2861439T3 (es) 2012-03-14 2021-10-06 Novan Inc Composiciones farmacéuticas que liberan óxido nítrico
US9855211B2 (en) 2013-02-28 2018-01-02 Novan, Inc. Topical compositions and methods of using the same
US11813284B2 (en) 2013-08-08 2023-11-14 Novan, Inc. Topical compositions and methods of using the same
US10322082B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
EP3166593B1 (en) 2014-07-11 2020-05-20 Novan, Inc. Topical antiviral compositions and methods of using the same
US10925689B2 (en) 2014-07-14 2021-02-23 Novan, Inc. Nitric oxide releasing nail coating compositions, nitric oxide releasing nail coatings, and methods of using the same
EP3177262A4 (en) 2014-08-08 2018-04-18 Novan Inc. Topical emulsions
WO2017019614A1 (en) 2015-07-28 2017-02-02 Novan, Inc. Combinations and methods for the treatment and/or prevention of fungal infections
JP6426635B2 (ja) * 2016-01-27 2018-11-21 株式会社 資生堂 αゲル形成用組成物及びαゲル組成物
US10912743B2 (en) 2016-03-02 2021-02-09 Novan, Inc. Compositions for treating inflammation and methods of treating the same
US11166980B2 (en) * 2016-04-13 2021-11-09 Novan, Inc. Compositions, systems, kits, and methods for treating an infection
WO2018236803A1 (en) 2017-06-19 2018-12-27 Novan, Inc. Topical compositions and methods of using the same
WO2019169221A1 (en) 2018-03-01 2019-09-06 Novan, Inc. Nitric oxide releasing suppositories and methods of use thereof
KR102831159B1 (ko) 2018-04-16 2025-07-07 온퀄리티 파마슈티컬스 차이나 리미티드 암 치료의 부작용을 예방하거나 치료하기 위한 방법
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
KR102088809B1 (ko) * 2018-06-20 2020-03-13 연세대학교 산학협력단 산화질소 전달체 및 그 제조방법
GR1009789B (el) * 2019-03-18 2020-08-03 Ελενη Δημητριου Πατσιανιδη Αλοιφη για τη θεραπεια εγκαυματων
JP7395263B2 (ja) * 2019-04-01 2023-12-11 スリーエム イノベイティブ プロパティズ カンパニー 透明親水性紫外線吸収積層体、及び透明親水性紫外線吸収コーティング剤
JP7335362B2 (ja) 2019-06-12 2023-08-29 ヌーリオン ケミカルズ インターナショナル ベスローテン フェノーツハップ 過酸化ジアシルを生成するためのプロセス
EP3983369B1 (en) 2019-06-12 2023-08-02 Nouryon Chemicals International B.V. Process for the production of diacyl peroxides
EP3983340B1 (en) * 2019-06-12 2023-08-02 Nouryon Chemicals International B.V. Method for isolating carboxylic acid from an aqueous side stream
WO2020249689A1 (en) 2019-06-12 2020-12-17 Nouryon Chemicals International B.V. Process for the production of peroxyesters
EP3983368B1 (en) 2019-06-12 2023-08-02 Nouryon Chemicals International B.V. Process for the production of diacyl peroxides
US20230355662A1 (en) * 2019-06-19 2023-11-09 Zylo Therapeutics, Inc. Sulfur functionalized monoliths and particles derived from the same as nitric oxide carriers for pharmaceutical and cosmetic applications
JP7587639B2 (ja) * 2022-10-25 2024-11-20 ロート製薬株式会社 アクネ菌バイオフィルム破壊組成物

Family Cites Families (206)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3093219A (en) 1961-04-06 1963-06-11 Monte Copter Inc Plural-section airfoils
US3754368A (en) 1969-11-04 1973-08-28 Moore Perk Corp Sterile packaging method
US4393871A (en) 1977-06-27 1983-07-19 Vli Corporation Vaginal device
US4182827A (en) 1978-08-31 1980-01-08 Union Carbide Corporation Polyurethane hydrogels having enhanced wetting rates
CH655656B (https=) 1982-10-07 1986-05-15
US4822604A (en) 1985-05-20 1989-04-18 S. C. Johnson & Son, Inc. Local treatment of dandruff, seborrheic dermatitis, and psoriasis
US4829092A (en) 1987-07-27 1989-05-09 Chesebrough-Pond's Inc. Glycerol and diglycerol mixtures for skin moisturizing
MX21453A (es) 1989-07-07 1994-01-31 Ciba Geigy Ag Preparaciones farmaceuticas que se administran en forma topica.
US6017521A (en) 1989-10-31 2000-01-25 Columbia Laboratories, Inc. Use of polycarboxylic acid polymers to treat vaginal infections
GB9125712D0 (en) 1991-12-03 1992-01-29 Smithkline Beecham Plc Skin care composition
US5814666A (en) 1992-04-13 1998-09-29 The United States As Represented By The Department Of Health And Human Services Encapsulated and non-encapsulated nitric oxide generators used as antimicrobial agents
US5910316A (en) 1992-08-24 1999-06-08 The United States Of America, As Represented By The Department Of Health And Human Services Use of nitric oxide-releasing agents to treat impotency
US5691423A (en) 1992-08-24 1997-11-25 The United States Of America As Represented By The Department Of Health And Human Services Polysaccharide-bound nitric oxide-nucleophile adducts
US5632981A (en) 1992-08-24 1997-05-27 The United States Of America As Represented By The Department Of Health And Human Services Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
US5405919A (en) 1992-08-24 1995-04-11 The United States Of America As Represented By The Secretary Of Health And Human Services Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders
JPH08502490A (ja) 1992-10-16 1996-03-19 スミスクライン・ビーチャム・コーポレイション 組成物
JP3739100B2 (ja) 1993-07-30 2006-01-25 救急薬品工業株式会社 低温架橋型ゲル剤
US5840759A (en) 1993-10-08 1998-11-24 The United States Of America As Represented By The Department Of Health And Human Services Use of nitric oxide releasing compounds to protect noncancerous cells from chemotherapeutic agents
GB9804469D0 (en) 1998-03-02 1998-04-29 Univ Aberdeen Antiviral composition
US6709681B2 (en) 1995-02-17 2004-03-23 Aberdeen University Acidified nitrite as an antimicrobial agent
US5519020A (en) 1994-10-28 1996-05-21 The University Of Akron Polymeric wound healing accelerators
DE19512181C2 (de) 1995-03-31 2003-11-06 Hexal Pharma Gmbh Transdermales System mit Ramipril und/oder Trandolapril als ACE-Hemmer
US5714511A (en) 1995-07-31 1998-02-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Selective prevention of organ injury in sepsis and shock using selection release of nitric oxide in vulnerable organs
US5968001A (en) 1996-05-14 1999-10-19 Bristol-Myers Squibb Company Wound dressings with leak prevention seal
US5770645A (en) 1996-08-02 1998-06-23 Duke University Medical Center Polymers for delivering nitric oxide in vivo
US5958427A (en) 1996-11-08 1999-09-28 Salzman; Andrew L. Nitric oxide donor compounds and pharmaceutical compositions for pulmonary hypertension and other indications
US5968528A (en) 1997-05-23 1999-10-19 The Procter & Gamble Company Skin care compositions
SE512663C2 (sv) 1997-10-23 2000-04-17 Biogram Ab Inkapslingsförfarande för aktiv substans i en bionedbrytbar polymer
US20020013304A1 (en) 1997-10-28 2002-01-31 Wilson Leland F. As-needed administration of an androgenic agent to enhance female sexual desire and responsiveness
JP4139860B2 (ja) 1997-11-10 2008-08-27 ストラカン インターナショナル リミティッド 浸透増強および刺激減少システム
US6103266A (en) 1998-04-22 2000-08-15 Tapolsky; Gilles H. Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues
US6103275A (en) 1998-06-10 2000-08-15 Nitric Oxide Solutions Systems and methods for topical treatment with nitric oxide
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6818018B1 (en) 1998-08-14 2004-11-16 Incept Llc In situ polymerizable hydrogels
US20040043068A1 (en) 1998-09-29 2004-03-04 Eugene Tedeschi Uses for medical devices having a lubricious, nitric oxide-releasing coating
US6382526B1 (en) 1998-10-01 2002-05-07 The University Of Akron Process and apparatus for the production of nanofibers
WO2000049993A2 (en) 1999-02-24 2000-08-31 Nitromed, Inc. Nitrosated and nitrosylated steroids for the treatment of cardiovascular diseases and disorders
GB2354441A (en) 1999-08-06 2001-03-28 Mccormack Ltd Composition for treating dentine hypersensitivity
US6479058B1 (en) 1999-09-02 2002-11-12 Mccadden Michael E. Composition for the topical treatment of poison ivy and other forms of contact dermatitis
DE19945484A1 (de) 1999-09-22 2001-04-05 Kolb Bachofen Victoria NO-freisetzende topisch applizierbare Zusammensetzung
US6737447B1 (en) 1999-10-08 2004-05-18 The University Of Akron Nitric oxide-modified linear poly(ethylenimine) fibers and uses thereof
US6719997B2 (en) 2000-06-30 2004-04-13 Dermatrends, Inc. Transdermal administration of pharmacologically active amines using hydroxide-releasing agents as permeation enhancers
US6627301B2 (en) 2000-03-28 2003-09-30 Showa Denko Kabushiki Kaisha Magnetic recording medium
DE60131644T2 (de) 2000-05-09 2008-10-30 Nitromed, Inc., Lexington Infrarotthermographie und behandlung von sexuellen dysfunktionen
US6475500B2 (en) 2000-07-10 2002-11-05 The Procter & Gamble Company Anhydrous cosmetic compositions
HUP0002628A2 (en) 2000-07-14 2002-06-29 Keri Pharma Kft Pharmaceutical combinations for treating diabetes
AU2002235545A1 (en) 2000-08-25 2002-03-04 Queen Mary & Westfield College Assay for s-nitrosothiol compounds
GB0022084D0 (en) 2000-09-08 2000-10-25 Univ Aberdeen Treatment of multiply antibiotic-resistant organisms
US20020122771A1 (en) 2000-09-23 2002-09-05 Troy Holland Spray hydrogel wound dressings
WO2002041902A1 (en) 2000-11-27 2002-05-30 The University Of Akron Treatment of disorders using polyethylenimine diazeniumdiolate
US7060732B2 (en) 2000-12-12 2006-06-13 Imaginative Research Associates, Inc. Antibiotic/benzoyl peroxide dispenser
US6780849B2 (en) 2000-12-21 2004-08-24 Scimed Life Systems, Inc. Lipid-based nitric oxide donors
US20040009238A1 (en) 2002-07-09 2004-01-15 Chris Miller Exogenenous nitric oxide gas (gNO) therapy in wound healing
US6706274B2 (en) 2001-01-18 2004-03-16 Scimed Life Systems, Inc. Differential delivery of nitric oxide
GB0119011D0 (en) 2001-08-03 2001-09-26 Univ Aberdeen Treatment of nail infections
US6520425B1 (en) 2001-08-21 2003-02-18 The University Of Akron Process and apparatus for the production of nanofibers
US6703046B2 (en) 2001-10-04 2004-03-09 Medtronic Ave Inc. Highly cross-linked, extremely hydrophobic nitric oxide-releasing polymers and methods for their manufacture and use
US6846846B2 (en) 2001-10-23 2005-01-25 The Trustees Of Columbia University In The City Of New York Gentle-acting skin disinfectants
US6765001B2 (en) 2001-12-21 2004-07-20 Medicis Pharmaceutical Corporation Compositions and methods for enhancing corticosteroid delivery
JP2003212773A (ja) 2002-01-04 2003-07-30 Oramon Arzneimittel Gmbh セチリジン及びロラタジンの局所医薬組成物
WO2003056951A2 (en) 2002-01-08 2003-07-17 Bernard Techologies, Inc. Antimicrobial body covering articles
US20030159702A1 (en) 2002-01-21 2003-08-28 Lindell Katarina E.A. Formulation and use manufacture thereof
US6695992B2 (en) 2002-01-22 2004-02-24 The University Of Akron Process and apparatus for the production of nanofibers
JP2003286153A (ja) 2002-01-24 2003-10-07 Shiseido Co Ltd 皮膚外用組成物
JP4229842B2 (ja) 2002-02-22 2009-02-25 ルバンス セラピュティックス インク. L−アルギニンオリゴマーを含む化粧品処方
US20030175328A1 (en) 2002-03-06 2003-09-18 Adi Shefer Patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients into the skin
DK1532974T3 (da) 2002-03-12 2009-05-11 Galderma Res & Dev Sammensætning, der omfatter 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthsyre, til behandling af dermatologiske lidelser
JP2005524676A (ja) 2002-03-20 2005-08-18 ザ・ユニバーシティ・オブ・クイーンズランド 一酸化窒素供与体及びオピオイド鎮痛薬を含む方法及び組成物
AU2003223491A1 (en) 2002-04-05 2003-10-27 Nitromed, Inc. Nitric oxide donors, compositions and methods of use
AU2003237128A1 (en) 2002-05-03 2003-11-17 Duke University Carbon nanotubules for storage of nitric oxide
US7328706B2 (en) 2002-05-06 2008-02-12 Dynamic Mouth Devices Llc Therapeutic and protective dental device useful as an intra-oral delivery system
CA2485167A1 (en) 2002-05-07 2003-11-20 The Government Of The United States Of America Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same
EP1534278A4 (en) 2002-08-01 2006-09-06 Nitromed Inc NITROSED PROTONATE PUMP INHIBITORS, COMPOSITIONS AND USE METHOD
EP1545798A4 (en) 2002-08-02 2006-06-14 Us Gov Health & Human Serv NETWORKED NITROGEN OXIDE RELEASING POLYAMINE-COATED SUBSTRATES, THESE COMPOSITIONS AND MANUFACTURING PROCESSES DAF R
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US20080317679A1 (en) 2002-10-25 2008-12-25 Foamix Ltd. Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
US20080031907A1 (en) 2002-10-25 2008-02-07 Foamix Ltd. Cosmetic and pharmaceutical foam
US20050271596A1 (en) 2002-10-25 2005-12-08 Foamix Ltd. Vasoactive kit and composition and uses thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US20070292359A1 (en) 2002-10-25 2007-12-20 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
US20080206161A1 (en) 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US20070292461A1 (en) 2003-08-04 2007-12-20 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
FR2850579B1 (fr) 2003-02-03 2006-08-18 Oreal Utilisation de mono-ou di-esters d'acide cinnamique ou de l'un de ses derives et de vitamine c, comme donneur de no
EP1603933A2 (en) 2003-03-13 2005-12-14 Nitromed, Inc. Nitrosated and nitrosylated compounds, compositions and methods of use
US20040202684A1 (en) 2003-04-08 2004-10-14 David Djerassi Personalized interactive natural cosmetics
WO2004093886A1 (en) 2003-04-24 2004-11-04 Galderma S.A. Topical formulation of ivermectin for the treatment of dermatological conditions
US7879357B2 (en) 2003-04-28 2011-02-01 Bayer Schering Pharma Ag Pharmaceutical composition in the form of a hydrogel for transdermal administration of active ingredients
EP1491188A1 (en) 2003-06-25 2004-12-29 G2M Cancer Drugs AG Topical use of valproic acid for the prevention or treatment of skin disorders
US7972137B2 (en) 2003-06-30 2011-07-05 Rosen Gerald M Anti-microbial dental formulations for the prevention and treatment of oral mucosal disease
NZ545001A (en) 2003-07-03 2009-09-25 Univ St Andrews Zeolites for delivery of nitric oxide
WO2005004984A1 (en) 2003-07-14 2005-01-20 Power Paper Ltd. Device and method for the treatment of pilosebaceous disorders
EP1648527A4 (en) 2003-07-25 2008-04-23 Univ Akron STABILIZATION AND IONIC RELEASE OF NITRIC OXIDE RELEASE
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US20080069779A1 (en) 2003-08-04 2008-03-20 Foamix Ltd. Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof
MXPA06001381A (es) * 2003-08-04 2006-05-19 Foamix Ltd Vehiculo de espuma que contiene un gelificante copolimerico anfifilico.
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
WO2005037339A1 (en) 2003-10-14 2005-04-28 Cube Medical A/S A balloon for use in angioplasty
GB0326047D0 (en) 2003-11-07 2003-12-10 Univ Sheffield Substance
US8017074B2 (en) 2004-01-07 2011-09-13 Noxilizer, Inc. Sterilization system and device
PT1734927E (pt) 2004-04-08 2012-09-05 Meda Pharma S A R L Composição em espuma de pimecrolimus contendo hexilenoglicol, opcionalmente álcool oleílico, dimetilisossorbida e/ou triglicéridos de cadeia média
US9050365B2 (en) 2004-04-19 2015-06-09 Strategic Science & Technologies, Llc Transdermal delivery of beneficial substances effected by a hostile biophysical environment
US20070166255A1 (en) 2004-11-22 2007-07-19 Gupta Shyam K Treatment of Topical Discomforts Including Acne, Sunburn, Diaper Rash, Wound, Wrinkles and Dandruff/Hair Loss by Natural Lignans via Fatty Acid Desaturase Inhibition
JP5188184B2 (ja) * 2004-11-29 2013-04-24 ザ ユニバーシティ オブ アクロン 局所的一酸化窒素供給装置およびその治療的使用方法
SI1833443T1 (sl) 2005-01-04 2012-03-30 Teikoku Pharma Usa Inc Hladilni pripravek v obliki topičnega obliža
ES2314882T3 (es) 2005-02-11 2009-03-16 Nolabs Ab Dispositivo y metodo para el tratamiento de dermatomicosis y, en particular, de onicomicosis.
EP1757278A1 (en) 2005-08-23 2007-02-28 NOLabs AB Device, system, and method comprising microencapsulated liquid for release of nitric oxide from a polymer
PL1846058T3 (pl) 2005-02-11 2009-12-31 Nolabs Ab Produkt, sposób i zastosowanie go do leczenia neuropatii z wydzielaniem tlenku azotu
EP1690554A1 (en) 2005-02-11 2006-08-16 NOLabs AB Device for treatment of infections, including dermatophytosis and onychomycosis
US20080171795A1 (en) 2005-03-21 2008-07-17 Life-Care Innovations Pvt. Ltd. Novel Inter and Intra Multilamellar Vesicular Composition
EP1704876A1 (en) 2005-03-24 2006-09-27 NOLabs AB Cosmetic treatment, device for performing said treatment and manufacturing method thereof
EP1871433B1 (en) 2005-03-24 2009-04-22 NOLabs AB Cosmetic treatment with nitric oxide, device for performing said treatment and manufacturing method therefor
WO2007039825A2 (en) 2005-05-09 2007-04-12 Foamix Ltd. Saccharide foamable compositions
FR2885527B1 (fr) 2005-05-16 2007-06-29 Galderma Res & Dev Composition pharmaceutique comprenant un onguent oleagineux et de la vitamine d ou ses derives a l'etat solubilise
EP1888510A4 (en) 2005-05-27 2013-01-16 Univ North Carolina NITROGEN OXIDE-RELATED PARTICLES FOR NITROGEN OXIDE THERAPEUTICS AND BIOMEDICAL APPLICATIONS
WO2006138035A1 (en) 2005-06-13 2006-12-28 Dow Corning Corporation Vehicle for the delivery of topical lipid soluble pharmaceutical agents
US20080152596A1 (en) 2005-07-19 2008-06-26 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
WO2007092312A2 (en) 2006-02-03 2007-08-16 Stiefel Laboratories, Inc. Topical skin treating compositions
US7744928B2 (en) * 2006-04-14 2010-06-29 Advanced Cardiovascular Systems, Inc. Methods and compositions for treatment of lesioned sites of body vessels
EP2029106A2 (en) 2006-06-07 2009-03-04 Foamix Ltd. Foamable vehicle comprising polypropylene glycol alkyl ether and pharmaceutical compositions thereof
US8333997B2 (en) 2006-06-21 2012-12-18 Albert Einstein College Of Medicine Of Yeshiva University Compositions for sustained release of nitric oxide, methods of preparing same and uses thereof
WO2008110872A2 (en) 2006-06-23 2008-09-18 Foamix Ltd. Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
WO2008038147A2 (en) 2006-07-05 2008-04-03 Foamix Ltd. Foamable vehicle comprising dicarboxylic acid or dicarboxylic acid ester and pharmaceutical compositions thereof
GB0616350D0 (en) 2006-08-17 2006-09-27 Univ St Andrews Adsorption and release of nitric oxide in metal organic frameworks
US20080166303A1 (en) 2006-09-08 2008-07-10 Dov Tamarkin Colored or colorable foamable composition and foam
EP1923041A1 (de) 2006-10-20 2008-05-21 Symrise GmbH & Co. KG Verwendung von C10-C14-Alkandiolen zur Herstellung eines Mittels zur Prophylaxe und/oder Behandlung von Malassezia-induzierter Schuppenbildung, sowie Zubereitungen enthaltend C10-C14-Alkandiole
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
WO2009007785A2 (en) 2006-11-14 2009-01-15 Foamix Ltd. Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
EP2097065A2 (en) 2006-11-29 2009-09-09 Foamix Ltd. Foamable waterless compositions with modulating agents
FR2910320B1 (fr) 2006-12-21 2009-02-13 Galderma Res & Dev S N C Snc Emulsion comprenant au moins un retinoide et du peroxyde de benzole
US20080292560A1 (en) 2007-01-12 2008-11-27 Dov Tamarkin Silicone in glycol pharmaceutical and cosmetic compositions with accommodating agent
US8530436B2 (en) 2007-01-29 2013-09-10 Transderm, Inc. Methods and compositions for transdermal delivery of nucleotides
US20100178319A1 (en) 2007-03-27 2010-07-15 Lars Lindgren Topical Dermal Delivery Device For Nitric Oxide Delivery
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009056991A2 (en) 2007-09-04 2009-05-07 Foamix Ltd. Device for delivery of a foamable composition
US8399005B2 (en) 2007-10-12 2013-03-19 University Of North Carolina At Chapel Hill Use of nitric oxide to enhance the efficacy of silver and other topical wound care agents
EP2219600A4 (en) 2007-11-19 2012-09-12 Stiefel Laboratories TOPICAL COSMETIC SKIN COMPOSITIONS AND APPLICATION METHOD THEREFOR
US20090130029A1 (en) 2007-11-21 2009-05-21 Foamix Ltd. Glycerol ethers vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US8557911B2 (en) 2007-12-27 2013-10-15 Eastman Kodak Company Aqueous colloidal dispersions stabilized with polymeric dispersants
CA2711703A1 (en) 2008-01-08 2009-07-16 Foamix Ltd. Sensation modifying topical composition foam
FR2929278A1 (fr) 2008-04-01 2009-10-02 Centre Nat Rech Scient Solide hybride cristallin poreux pour l'adsorption et la liberation de gaz a interet biologique.
CN102065848A (zh) * 2008-04-21 2011-05-18 3M创新有限公司 释放一氧化一氮的组合物、装置和方法
US20120141384A1 (en) 2008-05-06 2012-06-07 Dov Tamarkin Antibacterial conjugated boronic acids and pharmaceutical compositions thereof
KR101199580B1 (ko) 2008-08-06 2013-11-27 (주)에델프라우 국소 투여용 나노에멀젼
WO2010044875A2 (en) 2008-10-16 2010-04-22 Novan, Inc. Nitric oxide releasing particles for oral care applications
CA2766116C (en) 2009-07-07 2017-12-05 Convatec Technologies Inc. Pressure sensitive silicone adhesives with amphiphilic copolymers
WO2011022652A1 (en) * 2009-08-21 2011-02-24 Novan, Inc. Topical gels
BR112012003804B1 (pt) 2009-08-21 2019-02-19 Novan, Inc. Curativo para ferimentos, método para formar um curativo para ferimentos, e, kit de curativo para ferimento
EP2482816B8 (en) 2009-10-01 2016-12-14 Imuneks Farma Ilaç Sanayi Ve Ticaret A.S. Topical compositions of naltrexone for treating skin conditions
WO2011047013A1 (en) 2009-10-13 2011-04-21 Novan, Inc. Nitric oxide-releasing coatings
CA2781580A1 (en) 2009-11-23 2011-05-26 Cipla Limited Topical foam composition
ES2541483T3 (es) 2009-12-16 2015-07-21 Shasun Pharmaceuticals Limited Composición de hidrogel transdérmico de dexibuprofeno
WO2011085484A1 (en) 2010-01-13 2011-07-21 Nitric Solutions Inc. Antimicrobial nitric oxide compositions
CN101791411B (zh) 2010-01-25 2012-05-23 中国药科大学 两亲性多糖偶联物及其药物组合物的制备和应用
CN101732728B (zh) 2010-01-25 2012-11-14 中国药科大学 抗炎药物-多糖偶联物及其药物组合物的制备和应用
EP2560634A1 (en) 2010-04-23 2013-02-27 Piramal Enterprises Limited Nitric oxide releasing prodrugs of therapeutic agents
EP2387990A1 (en) 2010-05-06 2011-11-23 Skinius S.R.L. Topical composition and use thereof for the prophylaxis and the treatment of defects connected to inflammatory dermopathies
GB201010954D0 (en) 2010-06-29 2010-08-11 Edko Pazarlama Tanitim Ticaret Compositions
EA015747B1 (ru) 2010-07-08 2011-10-31 Общество С Ограниченной Ответственностью "Вдс" Состав для профилактики кандидозов
CN102958511A (zh) 2010-07-14 2013-03-06 道康宁公司 使用有机硅凝胶的双药物递送
WO2012035468A2 (en) 2010-09-14 2012-03-22 Trima - Israel Pharmaceutical Products Maabarot Ltd. Foamable topical composition
US8591876B2 (en) * 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
CN102100663B (zh) 2011-01-14 2013-04-17 华南理工大学 一种pH敏感型原位凝胶纳米缓释眼药水的制备方法
EP2665763B1 (en) 2011-01-20 2015-08-26 Novan, Inc. Temperature controlled sol-gel co-condensation
ES2695173T3 (es) 2011-02-28 2019-01-02 Novan Inc Partículas de sílice modificadas con S-nitrosotiol que liberan óxido nítrico y procedimientos de fabricación de las mismas
CN103547258B (zh) 2011-03-17 2017-10-20 特兰斯德梅尔生物工艺股份有限公司 局部一氧化氮系统及其使用方法
WO2012153331A2 (en) 2011-05-09 2012-11-15 Topical Therapeutic Agent (Tta) Ltd. Nitric oxide-sequestering topical formulations
WO2013006613A1 (en) 2011-07-05 2013-01-10 Novan, Inc. Methods of manufacturing topical compositions and apparatus for same
ES2804263T3 (es) 2011-07-05 2021-02-05 Novan Inc Composiciones tópicas
ES2658897T3 (es) 2011-08-24 2018-03-12 Novan, Inc. Macromoléculas de liberación de óxido nítrico ajustables que tienen múltiples estructuras donantes de óxido nítrico
WO2013063354A1 (en) 2011-10-27 2013-05-02 Novan, Inc. Nitric oxide releasing bath compositions and methods of using the same
US20150111973A1 (en) 2012-03-13 2015-04-23 Novan, Inc. Methods of modulating steroid hormone activity
ES2861439T3 (es) * 2012-03-14 2021-10-06 Novan Inc Composiciones farmacéuticas que liberan óxido nítrico
JP6206987B2 (ja) 2012-05-11 2017-10-04 メディカス バイオサイエンシーズ,エルエルシー 網膜剥離の処置のための生体適合性ヒドロゲル製剤
US9540471B2 (en) 2012-07-17 2017-01-10 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Nitric oxide-releasing diazeniumdiolated polyvinylpyrrolidone-based polymers, and compositions, medical devices, and uses thereof
EP2885323B1 (en) 2012-08-17 2023-08-30 The University of North Carolina At Chapel Hill Water soluble nitric oxide-releasing polyglucosamines and uses thereof
US9187501B2 (en) 2012-08-28 2015-11-17 The University Of North Carolina At Chapel Hill Nitric oxide-releasing nanorods and their methods of use
US9855211B2 (en) 2013-02-28 2018-01-02 Novan, Inc. Topical compositions and methods of using the same
EP2968088B1 (en) 2013-03-15 2025-10-22 Leading Edge Innovations, LLC Substantially surfactant-free, submicron dispersions of hydrophobic agents containing high levels of water miscible solvent
US11813284B2 (en) 2013-08-08 2023-11-14 Novan, Inc. Topical compositions and methods of using the same
US20150259283A1 (en) 2014-03-13 2015-09-17 Brickell Biotech, Inc. Formulation for soft anticholinergic analogs
US10322082B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
EP3166593B1 (en) 2014-07-11 2020-05-20 Novan, Inc. Topical antiviral compositions and methods of using the same
US10925689B2 (en) 2014-07-14 2021-02-23 Novan, Inc. Nitric oxide releasing nail coating compositions, nitric oxide releasing nail coatings, and methods of using the same
EP3177262A4 (en) 2014-08-08 2018-04-18 Novan Inc. Topical emulsions
CN119033771A (zh) 2015-07-21 2024-11-29 博多尔实验仪器公司 软性抗胆碱能药类似物的制剂
EP3346998B1 (en) 2015-08-17 2025-04-16 Sidmak Laboratories (India) PVT. Ltd. Topical film delivery system
US10912743B2 (en) 2016-03-02 2021-02-09 Novan, Inc. Compositions for treating inflammation and methods of treating the same
AR108116A1 (es) 2016-04-11 2018-07-18 Biolab Sanus Farmaceutica Ltda Composición dermocosmética, proceso de producción de la composición tópica, método para fortalecimiento de uñas frágiles y uso de la composición
US11166980B2 (en) 2016-04-13 2021-11-09 Novan, Inc. Compositions, systems, kits, and methods for treating an infection
TWI767507B (zh) 2016-07-21 2022-06-11 美商波德實驗股份有限公司 軟性抗膽鹼類似物之製劑
US10668002B2 (en) 2018-01-18 2020-06-02 Regenesis Group Anhydrous polysaccharide films
WO2019169221A1 (en) 2018-03-01 2019-09-06 Novan, Inc. Nitric oxide releasing suppositories and methods of use thereof
SG11202111168UA (en) 2019-04-09 2021-11-29 Dermbiont Inc Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with pathogenic microbes
GB2599818B (en) 2019-06-04 2024-01-31 Thirty Respiratory Ltd Methods and compositions for generating nitric oxide and uses thereof to deliver nitric oxide via the respiratory tract
US11419809B2 (en) 2019-06-27 2022-08-23 L'oreal Hair treatment compositions and methods for treating hair
AU2020328026A1 (en) 2019-08-14 2022-03-03 Nanometics Llc (D.B.A. Phd Biosciences) Uracil dermal pharmaceutical formulation
CA3174550A1 (en) 2020-03-03 2021-09-10 Kaken Pharmaceutical Co., Ltd. Medicament containing sofpironium bromide
EP4157290A4 (en) 2020-06-02 2024-06-05 National University of Singapore COMPOSITIONS, THEIR USES IN THERAPY AND METHODS THEREFOR
KR20230058444A (ko) 2020-08-26 2023-05-03 오티카라 인코포레이티드 코, 귀 및 다른 조직 감염 및/또는 염증을 치료하기 위한 조성물, 디바이스 및 방법
CN112402615A (zh) 2020-11-11 2021-02-26 长沙晶易医药科技有限公司 一种用于治疗斑秃的复方外用制剂及其制备方法
US20240131103A1 (en) 2021-02-18 2024-04-25 Lyrus Life Sciences Pvt Ltd Novel arthritis emulgel composition and its preparation process

Similar Documents

Publication Publication Date Title
JP2017526738A5 (https=)
JP2012131827A5 (https=)
Lee et al. Thixotropic property in pharmaceutical formulations
JP2018526325A5 (https=)
MX355174B (es) Formulaciones de uso topico de tetraciclina, preparaciones y usos de las mismas.
BRPI0615292A8 (pt) composições e métodos para preparação de fármacos de má solubilidade em água com estabilidade aumentada
RU2011134420A (ru) Жидкие композиции, способные к пенообразованию и включающие активные средства, и способы их получения и разработки
EP2364692A3 (fr) Compositions comprenant au moins un derive de l'acide naphtoïque, du peroxyde de benzoyle et au moins un agent filmogene, leurs procedes de preparation, et leurs utilisations
US10828250B2 (en) Topical formulation
JP2014139241A5 (https=)
JP2009544665A5 (https=)
JP2017505791A (ja) 安定化されたケイ酸塩組成物及び制汗剤組成物としてのその使用
JP2013525335A5 (https=)
MX2010005901A (es) Sustituto de crema liquido no perecedero y proceso para hacer el mismo.
HRP20230299T3 (hr) Farmaceutski pripravci koji sadrže visoko hlapljive silikone
JP2016532654A5 (https=)
CO7101247A2 (es) Formulaciones de ácido poliinosínico-policitidílico (poli(i:c)) para el tratamiento de infecciones de las vías respiratorias altas
JP2021073194A5 (https=)
JP2015504860A5 (https=)
JP2017503828A (ja) 皮膚及び粘膜を局所処置するための、多価アルコール及びコレカルシフェロールを含む組成物
JP2019530729A5 (https=)
HK1222337A1 (zh) 用於施加药物活性成分或化妆品活性成分的局部组合物和载体
JP2013253067A5 (https=)
JP2017502947A5 (https=)
US20230210835A1 (en) Composition for topical dermatological delivery